HER2-positive Locally Advanced or Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch HER2-positive Locally Advanced or Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer (NCT02514681) | Japan Breast Cancer Research Group | 2015-08-01 |
Track HER2-positive Locally Advanced or Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.